MitoRx Therapeutics

📍 Oxford, United Kingdom🗓 Founded 2021👥 9 employees💰 Last funded Oct 2023
Biotechnology Research🌐 mitorxtherapeutics.com
Website LinkedIn
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in MitoRx Therapeutics?
MitoRx Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did MitoRx Therapeutics last raise funding?
The most recent investment in MitoRx Therapeutics recorded on gritt.io was in October 2023.
When was MitoRx Therapeutics founded?
MitoRx Therapeutics was founded in 2021.
What industry is MitoRx Therapeutics in?
MitoRx Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MitoRx Therapeutics based?
MitoRx Therapeutics is headquartered in Oxford, United Kingdom.